47 results on '"Chandel, Abhimanyu"'
Search Results
2. Prevalence and Survival of Prolonged Venovenous Extracorporeal Membrane Oxygenation for Acute Respiratory Distress Syndrome: An Analysis of the Extracorporeal Life Support Organization Registry*
3. Derivation and validation of a noninvasive prediction tool to identify pulmonary hypertension in patients with IPF: Evolution of the model FORD
4. 538: OUTCOMES IN SEVERE ARDS: CARE AT A COMMUNITY HOSPITAL OR TRANSFER TO AN ECMO CENTER
5. Prolonged Noninvasive Respiratory Support Before Intubation Leads to Increased Duration of ECMO: More Evidence That Less Is More
6. Intensive Care and Organ Support Related Mortality in Patients With COVID-19: A Systematic Review and Meta-Analysis
7. Preclosure technique versus arterial cutdown after percutaneous cannulation for venoarterial extracorporeal membrane oxygenation
8. Duration of Noninvasive Respiratory Support and Extracorporeal Membrane Oxygenation Outcomes: Connecting the Dots
9. Duration of Noninvasive Respiratory Support and Extracorporeal Membrane Oxygenation Outcomes: Connecting the Dots
10. Pulmonary vascular dysfunction without pulmonary hypertension: A distinct phenotype in idiopathic pulmonary fibrosis
11. 538: OUTCOMES IN SEVERE ARDS: CARE AT A COMMUNITY HOSPITAL OR TRANSFER TO AN ECMO CENTER
12. Impact of Noninvasive Respiratory Support in Patients With COVID-19 Requiring V-V ECMO
13. Derivation and validation of a noninvasive prediction tool to identify pulmonary hypertension in patients with IPF: Evolution of the model FORD
14. Pulmonary Hypertension in Interstitial Lung Disease: Updates in Disease, Diagnosis, and Therapeutics
15. BILIRUBIN ELEVATION AND OUTCOMES IN EXTRACORPOREAL MEMBRANE OXYGENATION (ECMO) SUPPORT
16. 25: Prevalence and survival of prolonged venovenous ECMO for ARDS: an analysis of the Extracorporeal Life Support Organization Registry
17. External validation and longitudinal application of the DO-GAP index to individualise survival prediction in idiopathic pulmonary fibrosis
18. Prevalence of Pulmonary Hypertension in Patients with COVID‐19 Related Lung Disease Listed for Lung Transplantation: a UNOS Registry Analysis
19. Extracorporeal Membrane Oxygenation for COVID-19: Comparison of Outcomes to Non-COVID-19–Related Viral Acute Respiratory Distress Syndrome From the Extracorporeal Life Support Organization Registry
20. DERIVATION AND VALIDATION OF A SIMPLE MULTIDIMENSIONAL MODEL FOR IDENTIFICATION OF COEXISTING PULMONARY HYPERTENSION IN IDIOPATHIC PULMONARY FIBROSIS
21. AN UNUSUAL CASE OF SUBACUTE BACTERIAL ENDOCARDITIS PRESENTING WITH CATASTROPHIC SUBARACHNOID HEMORRHAGE
22. APPLICATION OF THE FORD MODEL FOR THE IDENTIFICATION OF COEXISTING PULMONARY HYPERTENSION IN PATIENTS WITH INTERSTITIAL LUNG DISEASE
23. Derivation and validation of a simple multidimensional index incorporating exercise capacity parameters for survival prediction in idiopathic pulmonary fibrosis.
24. Derivation and validation of a simple multidimensional index incorporating exercise capacity parameters for survival prediction in idiopathic pulmonary fibrosis
25. Transapical Cannulation With a Dual Lumen Cannula for Mechanical Circulatory Support in Cardiogenic Shock
26. Piecing together the bigger picture: Idiopathic pulmonary fibrosis in Australia and beyond
27. DURATION OF NON-INVASIVE RESPIRATORY SUPPORT AND CLINICAL OUTCOMES IN PATIENTS WITH SEVERE COVID-19 REQUIRING VENO-VENOUS EXTRACORPOREAL MEMBRANE OXYGENATION
28. INHALED NITRIC OXIDE VIA HIGH-FLOW NASAL CANNULA IN PATIENTS WITH ACUTE RESPIRATORY FAILURE RELATED TO COVID-19
29. Impact of an Initiative to Improve the Administration of Anticoagulation in High-Risk Patients
30. Antifibrotic Therapies and Progressive Fibrosing Interstitial Lung Disease (PF-ILD): Building on INBUILD
31. Incidence and prognostic significance of pleural effusions in pulmonary arterial hypertension
32. Association of D-dimer and Fibrinogen With Hypercoagulability in COVID-19 Requiring Extracorporeal Membrane Oxygenation
33. Agreement Between the TEG 6s and TEG 5000 Analyzers in Extracorporeal Membrane Oxygenation
34. High-Flow Nasal Cannula Therapy in COVID-19: Using the ROX Index to Predict Success
35. 63: D-Dimer and Fibrinogen Magnitude and Hypercoagulability by Thromboelastography in Severe COVID-19
36. 1186: Agreement Between the TEG 6s and TEG 5000 Analyzers in Assessment of Coagulation in Patients on ECMO
37. 1089: Cognitive Dysfunction Versus Cognitive Bias: A Reminder to Avoid Anchoring
38. Association of D-dimer and fibrinogen magnitude with hypercoagulability by thromboelastography in severe COVID-19
39. Decades of cough: delayed recognition of atypical cystic fibrosis in an adult patient
40. Agreement Between the TEG 6s and TEG 5000 Analyzers in Extracorporeal Membrane Oxygenation.
41. High-Flow Nasal Cannula Therapy in COVID-19: Using the ROX Index to Predict Success.
42. Diagnosis and Management of Rhabdomyolysis in the Absence of Creatine Phosphokinase: A Medical Record Review
43. Glycogenic Hepatopathy: Resolution with Minimal Glucose Control
44. Sa1366 Organ Failure on Day 1 of Hospitalization Predicts the Development of Pancreatic Necrosis in Patients With Acute Pancreatitis
45. Organ failure on day 1 of hospitalization predicts development of pancreatic necrosis in patients with acute pancreatitis
46. Relearning old lessons from a new disease: Prolonged noninvasive respiratory support for hypoxemic respiratory failure can harm patients.
47. Response to: Derivation and validation of a noninvasive prediction tool to identify pulmonary hypertension in patients with IPF: Evolution of the model FORD.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.